ArticleFrontiers in medicine2026

Denosumab versus zoledronic acid for primary osteoporosis: a 36-month retrospective cohort study on bone mineral density changes.

Xin Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.